Cecilia Ramirez received her master’s degree at the University of Maryland (College Park, USA) and her Ph.D. degree at the Institut Jacques Monod (Paris) from the Université Paris Diderot. She completed her training at Rutgers University (NJ, USA) as a Post-doctoral fellow and joined the French “Centre National de la Recherché Scientifique” (CNRS) in 1996. She is project leader at the Institut Cochin in Paris. She has focused her research work on the study of viruses-host interactions to understand the molecular mechanisms used by viruses to efficiently multiply by borrowing host’s cell machineries and metabolic pathways. Her team recently showed that spironolactone (SP) is a specific inhibitor of HIV Tat-dependent transcription. They continue to evaluate the transcription block by SP in several latent reservoir models to determine the possibility to use of SP to ‘‘block and lock’’ latent reservoirs leading to a functional cure of HIV as a new strategy to control HIV infection.
Abstract
TBA
HIV/AIDS and Retroviral Diseases
HIV Related Infections, Co-Infections and Cancers
HIV/AIDS stigma, Discrimination and Lived experience with HIV
HIV relation with Cardiovascular diseases and Aging
HIV Diagnosis and Therapy
HIV Drug Discovery, Research &Vaccines
Viral, Bacterial, Fungal & Protozoan STDs
STDs/STIs and Infertility
Immunology of STDs & STIs
Recent Advancement in HIV/AIDS, STDs and STIs
Current Focus in Virology Research
Policy, Advocacy& Community Engagement in HIV/ STI Research